Adriamycin was coupled to polyglutaraldehyde microspheres having an average diameter of 4500 A. The coupled microspheres remained stable during incubation with cells. Full cytostatic activity was observed when the coupled adriamycin was tested with murine or human leukemia and murine sarcoma cell lines. A 10-fold increase in sensitivity was obtained with drugresistant human leukemia cell lines. Repeated use of the coupled microspheres in the cytostatic assays did not decrease their activity, indicating that these complexes can be recycled. The results suggest that coupled adriamycin sufficiently perturbs the plasma membrane to lead to cytostatic activity. It is proposed that this mode of drug delivery provides multiple and repetitious sites for drug-cell interactions. In addition, the drug-polymer complexes may overcome those forms of resistance that are the result of decreased drug binding at the-cell surface.
The antibiotic adriamycin (Adr), an aminoglycosidic anthracycine, is used in the treatment of various human neoplasms (1) . Because ofthe clinical value ofAdr, its mode of action has been the subject of numerous investigations. Currently, the mechanism of action of this drug is considered to involve the intercalative binding of the anthracycline ring into DNA which results in the inhibition of DNA replication or RNA-synthesis (2) (3) (4) . In addition, it has been proposed that Adr must be converted initially to semiquinone species which exert their efficacy through DNA or RNA binding or through lipid peroxidation (5) . More recently, however, it has been demonstrated that Adr may have its effect through interactions on the cell surface membrane. Evidence for the cell surface as a possible site ofaction for Adr includes an enhanced rate ofconcanavalin A agglutination of murine sarcoma cells and an increased glycosylation of proteins on leukemia cell surfaces in the presence of the drug (6, 7) . It has also been shown that Adr alters the gelto-liquid crystal transition temperature of artificial membranes (8) .
In an effort to extend the studies of Adr membrane perturbation, we have designed polymeric microspheres to which Adr is chemically coupled. We now report the successful preparation of stable polyglutaraldehyde microspheres (PGLs) covalently coupled with Adr (Adr-PGLs) and. demonstrate that the bound drug retains its cytostatic activity. In addition, evidence for an altered cell surface topography induced by Adr-PGLs is presented.
METHODS AND MATERIALS Preparation of PGLs. Commercial glutaraldehyde was obtained as a 50% solution from Polysciences (Warrington, PA).
The PGLs were synthesized by the method of Margel and Rembaum (9) , after which they were washed extensively with 100 vol ofdouble-distilled water. The washed PGLs were then sonicated at 30'C for 2 min by using a needle-probe-type sonicator (Braun Sonic, Melsungen, Federal Republic of Germany) set at 100 W. After sonication, the PGLs were passed through a 1.2-,um Millipore filter disc in a Millipore vacuum filtration apparatus. The filtrate was collected and resuspended in 20% bovine serum albumin (Calbiochem). This mixture was centrifuged at 88 x g for 10 min and the supernate was discarded. The pellet was resuspended in double-distilled water and repeatedly washed in 200 vol of water. The average diameter of the microspheres was 4500 A as determined by small-angle light scattering with laser flow cytometry and confirmed by scanning electron microscopy.
Coupling of Adr. Adr hydrochloride was purchased from Sigma. A solution ofAdr was prepared by dissolving 6 mg ofthe drug in 5 ml of double-distilled water and adjusting to pH 6.5 with 0.1 M hydrochloric acid. One hundred milligrams of the PGLs was added to the Adr solution. The PGLs and Adr were allowed to react during 2 1/2 hr of continuous shaking. To stop the reaction, the mixture was centrifuged at 9500 X gfor 30 min. The concentration of the remaining Adr was determined by spectrofluoresence on an Aminco-Bowman spectrophotofluorometer (Silver Spring, MD). The labeled microspheres (Adr-PGLs) were treated with 10 ml of 0.5% Nonidet P-40 (Particle Data Laboratories, Elmhurst, IL) for 2 hr. Liposomes prepared by methods as described (10) and containing phosphatidylserine, phosphatidylcholine, and cholesterol in a 2:6:3 molar ratio were mixed with the microspheres for 1 hr at room temperature. Liposomes containing adsorbed Adr were dissolved in acetone and extracted with chloroform. The extract was concentrated and-rediluted in ethanol. Adr irreversibly bound to the microspheres was quantitated by difference after determining the concentration of Adr in the reaction solution and in each wash.
In order to establish the role of functional aldehyde groups of PGLs in the coupling ofAdr, the microspheres were reduced in 12% LiBH4. The reduced PGLs were collected, washed extensively, and used in the coupling reaction as described.
The Adr analog N-acetyldaunorubicin (NAc-DN), a generous gift of E. M. Acton (Stanford Research Institute, Palo Alto, CA) was used to establish the role of free amino groups in the coupling reaction. 
RESULTS
The PGL synthesis yielded a disperse population of microspheres ranging in diameter from 1000 to 10,000 A. Greater than 90% of the PGLs recovered after the sizing fractionations were determined to have diameters between 2500 and 6500 A (Fig. 1) . The mean diameter was estimated to be 4500 A and was confirmed by scanning electron microscopy.
After fractionation according to size, the PGLs were used for Adr coupling. The In order to test the cytostatic activity ofAdr-PGLs, IC50 was determined with free drug and Adr-PGLs. Fig. 2 illustrates typical IC50 curves obtained for free and bound Adr. Five cell lines were used to test for cytostatic activity (Table 2 ). In the case of the CCRF-CEM, L1210, and S-180 cell lines, the covalently coupled Adr was equally efficient as the free drug in the cytostatic assay. For CCRF-CEM/Vbl 500 and CCRF-CEM/Vbl 100 cell lines, the Adr-PGLs were approximately 10 times more active than free Adr.
Scanning electron microscopy of lymphocytic L1210 cells revealed cell surface alterations after treatment with low concentrations ofcoupled Adr (Fig. 3) . Untreated cells were spherical and displayed numerous microvilli on their surface. Cells treated with plain PGLs did not bind the microspheres and retained their characteristic roundness and microvilli. When L1210 cells were treated with Adr-PGLs for 24 hr at a drug concentration approximating the IC50 value, the cells bound the microspheres and the plasma membrane subsequently became devoid of all microvilli. In addition, the cell surface showed extensive blebbing. When L1210 cells were treated with free Adr under the same conditions, the lack of microvilli was apparent but there was no evidence of blebbing.
DISCUSSION
Adr covalently bound to a solid-phase support was chosen for study of the effects of the drug on the plasma membrane of (1982) Proc. Natl. Acad. Sci. USA 79 (1982) 2029 sess functional aldehyde groups to which Adr could be attached. The microspheres were size-fractionated to provide a defined population for subsequent studies. Conditions of fractionation were chosen to provide an enrichment of the 4500-A population and to allow efficient separation of microspheres from cells.
The coupling ofAdr to PGLs has been described.t However, we noted that the efficiency ofAdr coupling to the microspheres was extremely variable from one coupling reaction to the next. Based on this observation, significant nonspecific adsorption of Adr was suspected. Consequently, the coupled microspheres were treated with a nonionic detergent capable of removing the Adr that was not tightly bound to the PGLs. After detergent washing, the coupled microspheres were further treated with liposomes in order to remove all Adr molecules that could be detached by cellular plasma membranes. The liposomes, which are artificial membrane vesicles containing only lipid components, were able to remove a small portion ofthe remaining Adr and any residual detergent from prior treatments. Subsequent treatments with detergent, liposomes, and primary or secondary amines were not able to remove any detectable amounts of Adr. This indicates that the Adr remaining on the microspheres is firmly bound and cannot be removed by further washing or competition. Therefore, it is assumed that the remaining drug is covalently bound to the microspheres.
The nature of the bond between the microspheres and the covalently bound Adr was examined. Initially, the type of functional group present on the microspheres was investigated. It had been reported that the microspheres possessed aldehyde groups at their surfaces (9) . To verify the aldehyde groups as the Adr binding site, LiBH4 was used to reduce them to the corresponding alcohol groups. Although Adr could still be bound to the reduced PGLs, it could be completely removed by detergent treatment. This observation indicates that the aldehyde groups are required for covalent binding. In order to determine whether the anthracycline ring of Adr or its sugar moiety was involved in binding, the analog NAc-DN was used in the coupling reaction. Daunorubicin is identical to Adr except for an additional hydroxyl group on the anthracycline ring. Because both can be coupled to the PGLs, it was assumed that the hydroxyl group was not involved in the binding. The sugar residue of NAc-DN is acetylated on the amino group, thus eliminating it as a reactive site for PGL coupling. It was demonstrated that this analog cannot be coupled to the microspheres. From this data it can be concluded that the covalent coupling of Adr to PGLs occurs between an amino group and an aldehyde group. Therefore, the most likely coupling mechanism is a Schiff base condensation to form a stable imino complex. Preliminary evidence has been presented by other investigators for Schiffbase condensation between the Adr amino groups and the aldehyde groups on low molecular weight soluble polyglutaraldehyde (11) . After we determined that the drug was covalently bound to the microspheres, the stability ofthe bond was tested under cell culture conditions. The purpose of these experiments was to determine whether cells incubated with Adr-PGLs are capable of removing the drug from the microspheres. Incubations of Adr-PGLs with fetal calf serum, RPMI-1640 medium, or phosphate-buffered saline failed to release detectable amounts of Adr (<20 pmol). The coupled microspheres incubated in the presence of cells contained 1 ,uM coupled Adr. After 96 hr <0.1% (1.0 nmol) of the drug had been released from the Adr-PGLs as measured in the cell lysate. Free Adr was not detected in the culture supernatants. The intracellular concentrations of free Adr are no more than 1/10th the level of drug necessary for detection of cytostatic activity. Coupled microspheres not treated with liposomes prior to cell culture released a significantly higher amount of free Adr. Therefore, the drug-polymer complexes prepared by the described procedures remain stable during cell culture conditions and do not release free Adr.
It is ofconsiderable significance that the Adr coupled to PGLs retained the full activity of the free drug, as judged by the cytostatic assays using three sensitive cell lines (Table 2 ). In addition, cells that are resistant to free Adr become greater than 10 times more sensitive to the polymer-drug complex. When the Adr-PGLs are recovered from the IC50 determination and recycled for a second cytostatic assay they continue to retain their full activity. There are two implications of these experiments. First, in terms ofthe mechanisms ofAdr action, the findings suggest that DNA intercalation ofany form of the drug may not be essential for its pharmacological action. This interpretation can be made because Adr-PGLs recycled in the assays retain their full activity, which unequivocally demonstrates that the drug remains bound to the microspheres during all phases of cell growth and death. The nuclear components of the cell would therefore be inaccessible to Adr because the drug-polymer complex has a minimum size of 2000 A and the nuclear pore cannot accommodate structures larger than 110 A (12) . Although the data do not exclude the possibility that the Adr-PGLs could have their effect through one of the proposed cytoplasmic mechanisms, there is evidence to suggest that the cell membrane may be one of their primary sites of action. Preliminary data from fluorescence microscopy suggests that the coupled microspheres are localized entirely on the cell surface (unpublished data). In addition, aggregates ofmicrospheres were found adjacent to the cells and in contact with membranous components (Fig. 3C) . Scanning electron micrographs revealed that L1210 lymphocytes show extensive blebbing in the presence of Adr-PGLs. Blebbing appears to be the result of a separation of cytoplasmic microfilamentous cortex from the cell's periphery (13) . Endocytosis is known to require the assembly of microfilaments and microtubules beneath the site of attachment of the perturbing agent (14) . Therefore, blebbing could significantly decrease the possibility that Adr-PGLs would be endocytosed because of the detachment of the cytoskeletal elements from the cell's periphery.
The second implication is the possibility that polymer-bound Adr may increase the drug's toxicity. Although the IC50 values for the bound and free Adr are nearly identical for the three sensitive cell lines, the effective concentration of the coupled drug is even lower. This is a direct result of Adr being bound to a solid support, which would make a fraction of the drug molecules unavailable for cellular interactions due to steric effects. Finally, this mode of drug delivery provides multiple and repetitious sites for drug-cell interactions. If Adr resistance is acquired by reduced affinity for the drug, as recent evidence suggests (15, 16) , the repetitious interactions could overcome such resistance. In addition, free Adr undergoes metabolic degradation and inactivation in subcellular compartments after internalization. It is conceivable that the polymer-bound drug will not be available to these compartments in the same manner as the free drug which could lead to a decreased rate of metabolic breakdown. This would result in a continuous perturbation of the cell. The data obtained are consistent with both of these interpretations. 
